THE ASSESSMENT OF DNA DAMAGE BY ALKALINE COMET ASSAY IS NOT ASSOCIATED WITH CLINICAL OUTCOMES IN WOMEN WITH SYSTEMIC LUPUS ERYTHEMATOSUS
Authors:
- Camila De Melo Carvalho NascimentoCNCamila De Melo Carvalho Nascimento
- Lilian AlvesLALilian Alves
- Rodrigo Cutrim GaudioRGRodrigo Cutrim Gaudio
- Alice Ramos SilvaASAlice Ramos Silva
- Matheus Daudt LemosMLMatheus Daudt Lemos
- Mauro Jorge Cabral-CastroMCMauro Jorge Cabral-Castro
- Katia Lino BatistaKBKatia Lino Batista
- Ana Luísa Figueira GouvêaAGAna Luísa Figueira Gouvêa
- Jorge Reis AlmeidaJAJorge Reis Almeida
- Andrea Alice da SilvaASAndrea Alice da Silva
- Thalia MedeirosTMThalia Medeiros
- Fabiana Rabe CarvalhoFCFabiana Rabe Carvalho
Open Access
- 8 December 2023
- journal article
- research article
- Published by Universidade Alto Vale Do Rio Do Peixe - Uniarp in Revista Interdisciplinar de Estudos em Saúde
- Vol. 1 (1) , 133-146
Abstract
Introduction: In systemic lupus erythematosus (SLE), an inflammatory state leads to oxidative stress and excessive formation of reactive oxygen species, increasing cellular damage, mutations and compromised DNA repair. Therefore, our study aimed to evaluate the performance of the alkaline comet assay to investigate DNA damage in women with SLE.Methods: This is a cross-sectional study that included Brazilian women with SLE attended at an university hospital (Rio de Janeiro, Brazil) from 2015 to 2018. Disease activity was assessed using the SLE Disease Activity Index 2000 (SLEDAI-2K). Diagnosis of CMVand EBV infections were performed by qPCR. DNA damage was determined by alkaline comet assay, which is a electrophoresis techinique used to evaluate DNA fragmentation in leukocytes, which is expressed as arbitrary units (AU). Results: We studied 34 SLE patients with a median age of 34.5 years-old. Hospitalized patients (n=11, 32.3%) presented higher SLEDAI-2K, where 9 (81.8%) had SLEDAI-2K ≥ 5 (p=0.038). We did not identify significant differences between healthy and SLE; however, hospitalized patients showed higher median AU, but with no statistical significance (p=0.095). Also, no differences were in DNA damage according to SLEDAI-2, lupus nephritis, use of immunossupressants, or CMV/EBV infections. DNA damage was not associated with levels of anti-dsDNA. Lastlty, ROC curves demonstrated a poor predictive power of DNA damage to differentiate groups (AUC < 0.7, p > 0,05). Conclusion: Our results indicate that DNA damage measured by alkaline comet assay is not associated with SLE severity and the presence of viral infectionsKeywords
This publication has 32 references indexed in Scilit:
- Genetics of SLE: mechanistic insights from monogenic disease and disease-associated variantsNature Reviews Nephrology, 2023
- Systemic Lupus Erythematosus (SLE) Therapy: The Old and the NewRheumatology and Therapy, 2020
- Bone Marrow–Derived Mesenchymal Stem Cells From Patients With Systemic Lupus Erythematosus Have a Senescence‐Associated Secretory Phenotype Mediated by a Mitochondrial Antiviral Signaling Protein–Interferon‐β Feedback LoopArthritis & Rheumatology, 2017
- Different end-points to assess effects in systemic lupus erythematosus patients exposed to pesticide mixturesToxicology, 2017
- Antigenic role of the adaptive immune response to d -ribose glycated LDL in diabetes, atherosclerosis and diabetes atherosclerotic patientsLife Sciences, 2016
- Serious Infections Among Adult Medicaid Beneficiaries With Systemic Lupus Erythematosus and Lupus NephritisArthritis & Rheumatology, 2015
- N‐acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: A randomized, double‐blind, placebo‐controlled trialArthritis & Rheumatism, 2012
- Comet assay in neonatal sepsisIndian Journal of Pediatrics, 2010
- The DNA-damage response in human biology and diseaseNature, 2009
- Mutagen sensitivity of peripheral blood from women carrying a BRCA1 or BRCA2 mutationMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2002